Sulfamethoxazole/Trimethoprim Recalled

On June 2, 2025, Amneal Pharmaceuticals recalled three lots of sulfamethoxazole/trimethoprim tablets, USP, 400mg/80mg to the consumer level. Recalled lots may have black spots that could indicate microbial contamination. Products contaminated with Aspergillus could pose a serious or life-threatening risk for patients with underlying health conditions, especially those with immunosuppression. Sulfamethoxazole/trimethoprim is an antibiotic used for treating urinary tract infections, acute otitis media, acute exacerbations of chronic bronchitis, enteritis, and other bacterial infections. For full details about the recall, see here.